IM Cannabis (IMCC) Change in Receivables (2020 - 2026)
IM Cannabis' (IMCC) quarterly Change in Receivables came in at -$293140.7 in Q1 2026, up 70.06% year-on-year from -$172372.6 in Q1 2025, and down 154.36% quarter-over-quarter from $539248.9 in Q4 2025.
IM Cannabis (IMCC) Change in Receivables (2020 - 2026) Analysis & Trends
IM Cannabis' Change in Receivables history runs 7 years deep, the most recent figure standing at -$293140.7 for Q1 2026.
- On a quarterly basis, Change in Receivables rose 70.06% year-over-year to -$293140.7 in Q1 2026; TTM through Mar 2026 was $3.7 million, a 163.82% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 163.37% from the prior year.
- Change in Receivables eased to -$293140.7 in Q1 2026 per IMCC's latest filing, from $539248.9 in the prior quarter.
- Across five years, Change in Receivables topped out at $4.4 million in Q3 2022 and bottomed at -$5.0 million in Q2 2022.
- The 5-year median for Change in Receivables is $539248.9 (2025), against an average of $246162.0.
- Across the five-year window, Change in Receivables surged 374.15% in 2022 and tumbled 929.83% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $3.6 million in 2022, then tumbled by 44.97% to $2.0 million in 2023, then plunged by 30.84% to $1.4 million in 2024, then plunged by 60.29% to $539248.9 in 2025, then tumbled by 154.36% to -$293140.7 in 2026.
- Per Business Quant, the three latest IMCC Change in Receivables figures stand at -$293140.7 (Q1 2026), $539248.9 (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -293,140.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -293,140.69 |
| Mar 31, 2026 | -293,140.69 |
| Dec 31, 2025 | 539,248.88 |
| Dec 31, 2025 | 539,248.88 |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | -979,167.65 |
| Mar 31, 2025 | -979,167.65 |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Jun 30, 2024 | -4.37 Mn |
| Mar 31, 2024 | 117,996.00 |
| Mar 31, 2024 | 117,996.00 |
| Dec 31, 2023 | 1.96 Mn |
| Dec 31, 2023 | 1.96 Mn |